Search Results
Does using daratumumab make response-monitoring difficult?
Real-world daratumumab monotherapy
Treatment options for patients with multiple myeloma who are resistant to daratumumab
CyTOF flow cytometry in determining daratumumab response in myeloma
TOTAL Therapy 7: high response rates in high risk NDMM to daratumumab
When do you use daratumumab with lenalidomide/dexamethasone or bortezomib/dexamethasone in practice?
Promising results for daratumumab in the front line setting
Daratumumab with Ixazomib and Dex in Pts with One Prior Lenalidomide-Based Regimen: The DARIA Study
Daratumumab for the Treatment of Patients With Multiple Myeloma
Daratumumab Revolutionizing How Myeloma Is Treated
Efficacy and Safety of Daratumumab, Bortezomib, and Dex (D-Vd) Vs Vd in First Relapse Patients
Which patients will benefit the most from treatment with daratumumab and elotuzumab?
